Aug 16 2024 This Week in Cardiology

Aug 16 2024 This Week in Cardiology

Up next

Mar 20 2026 This Week in Cardiology

Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the controversial ACC/AHA lipid treatment guidelines are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professional ...  Show more

Mar 13 2026 This Week in Cardiology

Beta-blocker in non-obstructive hypertrophic cardiomyopathy, a head-to-head apixaban vs rivaroxaban RCT, diltiazem vs metoprolol combined with DOAC, and the accuracy of smart watches for AF are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intend ...  Show more

Recommended Episodes

Ep. 242 Advances in Posterior Nasal Nerve Ablation with Dr. Greg Davis
BackTable ENT

We’re keeping the chronic rhinitis conversation going in this week’s episode of BackTable ENT. Otolaryngologist Dr. Greg Davis joins Dr. Ashley Agan and Dr. Gopi Shah to break down his approach to posterior nasal nerve (PNN) ablation with the NeuroMark Gen 3, including patient pr ...  Show more

41: Do pulmonary artery catheters improve outcomes in cardiac surgery?
Depth of Anesthesia

Dr. Taylor Thomas and Dr. Matt Vanneman join the podcast to discuss the evidence on whether pulmonary artery catheters improve outcomes in cardiac surgery. Dr. Thomas is a dual obstetric and adult cardiothoracic anesthesia fellow at MGH and recent graduate of the anesthesia resid ...  Show more

Episode 072: Introduction to Diffuse Large B-Cell Lymphoma (DLBCL)
The Fellow on Call: The Heme/Onc Podcast

This week, we kick off a new series focusing on diffuse large B-cell lymphoma. In this first episode, we discuss the basics that everyone needs to understand before diving into the management of this disease.

<p class="" style="white- ...  Show more

Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
The Fellow on Call: The Heme/Onc Podcast

This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ...

  Show more